29Jul
National Retailer Pulls CBD Products From Shelves in Response to FDA Warning to Product Manufacturer
On Monday, July 22, the U.S. Food and Drug Administration (FDA) took a rare and significant step in issuing a warning letter to Curaleaf Holdings, Inc. (Curaleaf), one of the country’s larger producers of CBD-based products, regarding Curaleaf’s...
By:
Manatt, Phelps & Phillips, LLP
Related
Franczek recently hosted an at capacity seminar on preventing workplace violence. As a follow-up to ...
Read More >
Oil & gas dealmaking has plummeted following a period of prolonged low oil prices and a steep fall i...
Read More >
On December 20, 2019 the Taxpayer Certainty and Disaster Tax Relief Act of 2019 (2019 Disaster Act) ...
Read More >
Michigan’s Occupational Code (“Code”) requires builders of residential structures to be licensed ...
Read More >
In the fall of 2016, before the Obama administration increases to the minimum salary were set to go ...
Read More >
Over the last decade the use of R&W insurance in merger and acquisition transactions has grown expon...
Read More >